Omicron infection of vaccinated individuals enhances neutralizing immunity against the Delta variant.


Journal

medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986

Informations de publication

Date de publication:
28 Jan 2022
Historique:
pubmed: 5 1 2022
medline: 5 1 2022
entrez: 4 1 2022
Statut: epublish

Résumé

Omicron variant (B.1.1.529) infections are rapidly expanding worldwide, often in settings where the Delta variant (B.1.617.2) was dominant. We investigated whether neutralizing immunity elicited by Omicron infection would also neutralize the Delta variant and the role of prior vaccination. We enrolled 23 South African participants infected with Omicron a median of 5 days post-symptoms onset (study baseline) with a last follow-up sample taken a median of 23 days post-symptoms onset. Ten participants were breakthrough cases vaccinated with Pfizer BNT162b2 or Johnson and Johnson Ad26.CoV2.S. In vaccinated participants, neutralization of Omicron increased from a geometric mean titer (GMT) FRNT

Identifiants

pubmed: 34981076
doi: 10.1101/2021.12.27.21268439
pmc: PMC8722619
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Bill & Melinda Gates Foundation
ID : INV-018944
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI138546
Pays : United States

Commentaires et corrections

Type : UpdateIn
Type : UpdateIn

Références

Trop Med Int Health. 2022 Jun;27(6):564-573
pubmed: 35411997
Clin Infect Dis. 2022 Aug 24;75(1):e857-e864
pubmed: 34893824
Nature. 2021 May;593(7857):142-146
pubmed: 33780970
Nature. 2022 Mar;603(7902):679-686
pubmed: 35042229
Nat Rev Immunol. 2022 Feb;22(2):69-71
pubmed: 35046570
Lancet. 2022 Jan 29;399(10323):437-446
pubmed: 35065011
Lancet Infect Dis. 2020 Aug;20(8):e192-e197
pubmed: 32539990
Cell. 2022 Feb 3;185(3):457-466.e4
pubmed: 34995482
Clin Infect Dis. 2022 Aug 24;75(1):e822-e826
pubmed: 34915551
Med. 2022 Apr 8;3(4):262-268.e4
pubmed: 35313451
Nature. 2022 Feb;602(7898):671-675
pubmed: 35016199
Nature. 2022 Feb;602(7898):654-656
pubmed: 35016196

Auteurs

Khadija Khan (K)

Africa Health Research Institute, Durban, South Africa.
School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.

Farina Karim (F)

Africa Health Research Institute, Durban, South Africa.
School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.

Sandile Cele (S)

Africa Health Research Institute, Durban, South Africa.
School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.

James Emmanuel San (JE)

KwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa.

Gila Lustig (G)

Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.

Houriiyah Tegally (H)

KwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa.
Centre for Epidemic Response and Innovation, School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa.

Yuval Rosenberg (Y)

Department of Plant and Environmental Sciences, Weizmann Institute of Science, Rehovot, Israel.

Mallory Bernstein (M)

Africa Health Research Institute, Durban, South Africa.

Yashica Ganga (Y)

Africa Health Research Institute, Durban, South Africa.

Zesuliwe Jule (Z)

Africa Health Research Institute, Durban, South Africa.

Kajal Reedoy (K)

Africa Health Research Institute, Durban, South Africa.

Nokuthula Ngcobo (N)

Africa Health Research Institute, Durban, South Africa.

Matilda Mazibuko (M)

Africa Health Research Institute, Durban, South Africa.

Ntombifuthi Mthabela (N)

Africa Health Research Institute, Durban, South Africa.

Zoey Mhlane (Z)

Africa Health Research Institute, Durban, South Africa.

Nikiwe Mbatha (N)

Africa Health Research Institute, Durban, South Africa.

Yoliswa Miya (Y)

Africa Health Research Institute, Durban, South Africa.

Jennifer Giandhari (J)

KwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa.

Yajna Ramphal (Y)

KwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa.

Taryn Naidoo (T)

Africa Health Research Institute, Durban, South Africa.

Nithendra Manickchund (N)

Department of Infectious Diseases, Nelson R. Mandela School of Clinical Medicine, University of KwaZulu-Natal, Durban, South Africa.

Nombulelo Magula (N)

Department of Internal Medicine, Nelson R. Mandela School of Medicine. University of Kwa-Zulu Natal.

Salim S Abdool Karim (SS)

Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.
Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, United States.

Glenda Gray (G)

South African Medical Research Council, Cape Town, South Africa.

Willem Hanekom (W)

Africa Health Research Institute, Durban, South Africa.
Division of Infection and Immunity, University College London, London, UK.

Anne von Gottberg (A)

National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
SAMRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Ron Milo (R)

Department of Plant and Environmental Sciences, Weizmann Institute of Science, Rehovot, Israel.

Bernadett I Gosnell (BI)

Department of Infectious Diseases, Nelson R. Mandela School of Clinical Medicine, University of KwaZulu-Natal, Durban, South Africa.

Richard J Lessells (RJ)

KwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa.
Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.

Penny L Moore (PL)

Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.
National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
SAMRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.

Tulio de Oliveira (T)

KwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa.
Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.
Centre for Epidemic Response and Innovation, School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa.
Department of Global Health, University of Washington, Seattle, USA.

Mahomed-Yunus S Moosa (MS)

Department of Infectious Diseases, Nelson R. Mandela School of Clinical Medicine, University of KwaZulu-Natal, Durban, South Africa.

Alex Sigal (A)

Africa Health Research Institute, Durban, South Africa.
School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
Max Planck Institute for Infection Biology, Berlin, Germany.

Classifications MeSH